IP Library Granted Patent US 12,607,641
Granted Patent B2
US 12,607,641 · App. 15/526,757 · Granted Apr 21, 2026

Apparatus and method to determine stroke subtype

Inventors: Eli Cohen (Skokie, IL); Gabriel Raviv (Glenview, IL); Irene Navickas (Hauula, HI)
Assignee: Haemonetics Corporation
G01N33/86A61B5/150755C12Q1/56G01N33/6893G01N2333/974G01N2800/224G01N2800/2871
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,607,641
App. No.
15/526,757
Granted
Apr 21, 2026
Kind
B2
Abstract

Apparatus and methods are provided to determine stroke subtype by hemostasis measurement at point of care or first response. A testing apparatus and methods may provide first test to determine an ischemic or hemorrhagic indication and a second test to provide a therapeutic influence before classifying a stroke substype.

Claims (14)

1 . An apparatus to determine stroke subtype selected from acute ischemic stroke subtype and hemorrhagic stroke subtype, the system comprising:

operably coupled a transformative apparatus, a sensor and a processor;

the transformative apparatus being configured to excite a whole blood test sample to cause transformation of the whole blood test sample through thrombelastography;

the sensor being configured relative to the transformative apparatus to measure a physical characteristic of the whole blood test sample during transformation and to provide data representative of the physical characteristic; and

the processor being configured to control operation of the transformative apparatus to effect transformation of the whole blood test sample and to receive the data, the processor being further configured to determine a stroke index based at least on the data and to provide a stroke subtype indication based on a relationship of the stroke index to a set of cutoff values, wherein the stroke subtype indication is one of ischemic stroke subtype and hemorrhagic stroke subtype.

2 . The apparatus of claim 1 , wherein the transformative apparatus comprises a cartridge having first and second channels, the first and second channels corresponding to first and second transformations to be conducted on the whole blood test sample, respectively.

3 . The apparatus of claim 2 , wherein the first channel is configured according to a first assay and the second change is configured according to a second assay, different than the first assay.

4 . The apparatus of claim 1 , wherein the physical characteristic comprises at least one of a clotting time and a clot strength.

5 . The apparatus of claim 1 , wherein the set of cutoff values comprise a reference clotting time and a reference clot strength.

6 . The apparatus of claim 1 , wherein the set of cutoff values comprise a first reference clotting time and a first reference clot strength and a second reference clotting time different than the first reference clotting time and a second reference clot strength different than the first reference clot strength.

7 . The apparatus of claim 5 , wherein the set of cutoff values further comprise at least one biomarker.

8 . The apparatus of claim 1 , wherein the stroke subtype indication further comprises undetermined.

9 . The apparatus of claim 1 , wherein the physical characteristic comprises a resonant vibration frequency.

10 . The apparatus of claim 1 , further comprising a cartridge to determine stroke subtype selected from ischemic stroke subtype and hemorrhagic stroke subtype, the cartridge configured to be operably coupled to the transformative apparatus and comprises: a sample preparation portion including a fluid processing structure; a sample testing portion including a sample retention structure, the sample testing portion being coupled to the sample preparation portion via a fluidic passage providing fluid communication between the fluid processing portion and the sample retention structure; the sample retention structure supporting the whole blood test sample to be tested such that the whole blood test sample may be excited to resonant vibration responsive to an excitation applied to the cartridge by the transformative apparatus and observed by the sensor.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2022
From: CORA HEALTHCARE, INC.
To: CORAMED TECHNOLOGIES, LLC
Reel/Frame 060862/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2021
From: CORAMED TECHNOLOGIES, LLC
To: HAEMONETICS CORPORATION
Reel/Frame 054870/0781 →
Continuity (1)
Related Publication 20180238913A1 · Aug 23, 2018
References Cited (3)
US 9068966B2 · Delmenico · 2015 [cited by examiner]
US 20110117586A1 · Cohen · 2011 [cited by examiner]
US 20140328732A1 · Delmenico · 2014 [cited by examiner]